TP53 and osteosarcoma: Of note, all the seven analyzed osteosarcoma cell lines displayed loss of function alteration in the CDKN2A or in RB1 tumor suppressor (Table S2), loss of function or oncogenic mutation of TP53 gene, leading finally to the deregulation of p53 activity and cell cycle control.